We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

161 hedge funds and large institutions have $241M invested in Emergent Biosolutions in 2025 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

131% more call options, than puts

Call options by funds: $2.69M | Put options by funds: $1.17M

37% more capital invested

Capital invested by funds: $176M → $241M (+$65M)

33% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 40

6.47% more ownership

Funds ownership: 66.6% → 73.07% (+6.5%)

5% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 40

1% more funds holding

Funds holding: 160 → 161 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
161
Holders Change
+1
Holders Change %
+0.63%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
42
Increased
53
Reduced
40
Closed
40
Calls
$2.69M
Puts
$1.17M
Net Calls
+$1.53M
Net Calls Change
+$1.54M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$14.5M
2
OHA
Oak Hill Advisors
New York
+$14.3M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.82M
4
Pacer Advisors
Pacer Advisors
Pennsylvania
+$3.19M
5
Charles Schwab
Charles Schwab
California
+$2.99M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$10M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$4.24M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.47M
4
Goldman Sachs
Goldman Sachs
New York
-$2.93M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$1.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
GWSG
151
GPS Wealth Strategies Group
Colorado
$281 – – –
LWA
152
Lowe Wealth Advisors
Maryland
$255 – – –
NC
153
NewSquare Capital
Pennsylvania
$236 +$212 +37 New
GRP
154
Global Retirement Partners
California
$185 +$166 +29 New
TSMHT
155
Thurston Springer Miller Herd & Titak
Indiana
$140 – – –
MA
156
MCF Advisors
Kentucky
$64 – – –
SFCL
157
Strengthening Families & Communities LLC
Massachusetts
$57 – – –
National Bank of Canada
158
National Bank of Canada
Quebec, Canada
$6 -$1.37K -240 -100%
Northwestern Mutual Wealth Management
159
Northwestern Mutual Wealth Management
Wisconsin
$6 -$52 -9 -90%
HNB
160
Huntington National Bank
Ohio
$6 – – –
HF
161
HRT Financial
New York
– -$1.34M -275,716 Closed
SSA
162
Schonfeld Strategic Advisors
New York
– -$1.04M -213,861 Closed
OAC
163
OMERS Administration Corp
Ontario, Canada
– -$713K -146,700 Closed
SWM
164
SeaCrest Wealth Management
New York
– -$519K -106,700 Closed
YIH
165
Y-Intercept (HK)
Hong Kong
– -$462K -95,026 Closed
AIMCA
166
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$458K -94,200 Closed
EGM
167
Engineers Gate Manager
New York
– -$422K -86,910 Closed
OAM
168
Oxford Asset Management
United Kingdom
– -$313K -64,377 Closed
JG
169
Jain Global
New York
– -$311K -63,914 Closed
Nomura Holdings
170
Nomura Holdings
Japan
– -$310K -63,800 Closed
Verition Fund Management
171
Verition Fund Management
Connecticut
– -$299K -61,553 Closed
QC
172
Quantessence Capital
New York
– -$213K -43,817 Closed
LP
173
LMR Partners
United Kingdom
– -$177K -36,512 Closed
IQI
174
Integrated Quantitative Investments
Washington
– -$170K -35,023 Closed
CFM
175
Catalyst Funds Management
Australia
– -$154K -31,741 Closed
4 5 6
7
8

EBS Hedge Fund Activity: Q2 2025 in Review

161 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q2 2025, worth a combined $241M — up 37% from $176M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new EBS positions and 40 closed out — a net gain of 2 holders — while 53 added to existing stakes and 40 trimmed.

The largest buyer was BlackRock, adding an estimated $14.5M. The largest seller was Millennium Management, cutting an estimated $10M.

  • 161 institutional investors held Emergent Biosolutions (EBS) as of Q2 2025, up from 160 in Q1 2025.
  • Funds reported $241M of Emergent Biosolutions stock for Q2 2025, up 37% quarter-over-quarter.
  • 42 funds opened new Emergent Biosolutions positions in Q2 2025 and 40 closed out, a net change of +2 holders.
  • The largest Emergent Biosolutions buyer in Q2 2025 was BlackRock, an estimated $14.5M added.
  • The largest Emergent Biosolutions seller in Q2 2025 was Millennium Management, an estimated $10M sold.

Based on aggregated 13F filings for Q2 2025.